Rentokil Initial
RTO · LONDON
$22.77−$0.11 (−0.48%)TodayMarket closed ·
Prev close $22.88
EPS: actual vs estimate
Beat the estimate in 3 of the last 8 quarters, by 2.5% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | $0.1339 | $0.135 | +0.8% |
| Q4 FY25 | $0.1621 | $0.134 | −17.3% |
| Q2 FY25 | $0.1641 | $0.124 | −24.5% |
| Q4 FY24 | $0.1224 | $0.1238 | +1.1% |
| Q2 FY24 | $0.1469 | $0.1467 | −0.1% |
| Q4 FY23 | $0.1466 | $0.1462 | −0.2% |
| Q2 FY23 | $0.1443 | $0.1407 | −2.5% |
| Q4 FY22 | $0.1303 | $0.1377 | +5.7% |
Earnings calls
- Rentokil Initial plc, Q3 2026 Sales/ Trading Statement Call, Oct 22, 2026
- RTO.L - Earnings call Q2 2026
- Rentokil Initial plc, Q1 2026 Sales/ Trading Statement Call, Apr 16, 2026
- 2025 Earnings Call
- Rentokil Initial plc, Q3 2025 Sales/ Trading Statement Call, Oct 23, 2025
- Rentokil Initial plc, H1 2025 Earnings Call, Jul 31, 2025
- Rentokil Initial plc, Q1 2025 Sales/ Trading Statement Call, Apr 17, 2025
- 2024 Earnings Call
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.